cro.directory
← Compare landing

Inotiv vs Oncodesign Services

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/inotivco/oncodesign-services

CategoryInotivOncodesign Services
Listed sitecrocro
SummaryInotiv provides integrated preclinical and safety assessment services including toxicology, bioanalysis, pathology, and specialized research models across discovery through IND-enabling phases.Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.
Services
  • Translational Research
  • In Vitro Pharmacology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • GLP Toxicology
  • Genetic Toxicology
  • Safety Pharmacology
  • Carcinogenicity Studies
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Pathology & Histology Services
  • Proteomics Services
  • Genomics & Sequencing Services
  • Specialized & Large-Animal Models
  • Device & Combination Product Services
  • Cardiovascular & Metabolic Specialty Services
  • CNS Specialty Services
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Clinical Imaging Core Lab
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • GLP Toxicology
  • Safety Pharmacology
  • Translational Research
  • Preclinical In Vitro Studies
  • Regulatory Affairs
  • LC-MS Bioanalysis (Small Molecule)
  • High-Throughput Screening
  • Genetic Toxicology
  • Computational & In-Silico Drug Discovery
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Ligand-Binding Bioanalysis (Large Molecule)
Modalities
  • Cell Therapy
  • Gene Therapy
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
Indications
  • Cardiovascular
  • Gastroenterology
  • Infectious Disease
  • Immunology
  • Metabolic
  • Neurology
  • Oncology
  • Respiratory
  • Nephrology
  • Oncology
  • Immunology
  • Infectious Disease
  • Dermatology
  • Gastroenterology
  • Nephrology
  • Metabolic
  • Rare Disease
  • Respiratory
LocationsData not yet provided.
  • Headquarters, Dijon, Bourgogne-Franche-Comté, France
  • Headquarters
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.